GT Biopharma Announces Publication of Trike(TM) Results Targeting Multiple B7H3 Positive Cancers

BEVERLY HILLS, CA / ACCESSWIRE / October 21, 2020 / GT Biopharma, Inc.…

GT Biopharma Announces Selection of GTB-3550 Interim Results for Presentation at 62nd (ASH) American Society of Hematology Annual Meeting

BEVERLY HILLS, CA / ACCESSWIRE / October 15, 2020 / GT Biopharma,…

Micron Waste’s Subsidiary Ships Medical Grade Face Masks to a British Columbia Municipality and Submits Bids to Provincial Government Tenders

VANCOUVER, BC, Oct. 14, 2020 /CNW/ – Micron Waste Technologies Inc. (“Micron”…

GT Biopharma Announces Advisory Board Appointments

BEVERLY HILLS, CA / ACCESSWIRE / October 13, 2020 / GT Biopharma,…

GT Biopharma Announces Expanded TriKE(TM) Partnership With Cytovance Biologics

Sign $6,000,000.00 Agreement BEVERLY HILLS, CA / ACCESSWIRE / October 6, 2020…

GT Biopharma Announces GTB-3550 TriKE(TM) Phase I/II Clinical Trial Update

BEVERLY HILLS, CA / ACCESSWIRE / September 22, 2020 / GT Biopharma,…

Micron Waste’s Subsidiary starts to Manufacture Made in Canada Face Masks pursuant to its Medical Device Establishment License

VANCOUVER, BC, Sept. 21, 2020 /CNW/ – Micron Waste Technologies Inc. (“Micron”…

Penny Stock Evofem Biosciences (EVFM) Experiences “Odd” Side Effects

Insider Selling Sends EVFM Stock Spiraling Lower On September 11th

Algernon Announces Enrollment of 50th Patient in Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

VANCOUVER, British Columbia, Sept. 02, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…

Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder

TORONTO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…